Have your own idea? Try our Stock Screener
Pakistani (KSE) Healthcare Sector Analysis
UpdatedJul 16, 2025
DataAggregated Company Financials
Companies15
- 7D-2.1%
- 3M0.4%
- 1Y93.6%
- YTD-0.5%
Over the last 7 days, the Healthcare industry has dropped 1.5%, driven by pullbacks in Searle and GlaxoSmithKline Pakistan of 7.6% and 2.9%, respectively. On the other hand Highnoon Laboratories is actually up 5.5%. This takes the industry's 12 month performance to a gain of 96%. Looking forward, earnings are forecast to grow by 35% annually.
Sector Valuation and Performance
Has the Pakistani Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 16 Jul 2025 | PK₨545.3b | PK₨312.5b | PK₨28.6b | 20x | 19.1x | 1.7x |
| Fri, 13 Jun 2025 | PK₨528.5b | PK₨312.5b | PK₨28.6b | 18.4x | 18.5x | 1.7x |
| Sun, 11 May 2025 | PK₨430.7b | PK₨312.0b | PK₨28.1b | 15.1x | 15.3x | 1.4x |
| Tue, 08 Apr 2025 | PK₨519.5b | PK₨304.2b | PK₨25.4b | 19.8x | 20.5x | 1.7x |
| Thu, 06 Mar 2025 | PK₨510.5b | PK₨294.8b | PK₨22.9b | 20.1x | 22.3x | 1.7x |
| Sat, 01 Feb 2025 | PK₨543.6b | PK₨287.8b | PK₨20.9b | 23.6x | 25.9x | 1.9x |
| Mon, 30 Dec 2024 | PK₨514.7b | PK₨287.8b | PK₨20.9b | 19.6x | 24.6x | 1.8x |
| Wed, 27 Nov 2024 | PK₨422.2b | PK₨287.7b | PK₨20.8b | 18x | 20.3x | 1.5x |
| Fri, 25 Oct 2024 | PK₨339.6b | PK₨277.5b | PK₨16.5b | 19x | 20.5x | 1.2x |
| Sun, 22 Sep 2024 | PK₨295.6b | PK₨281.3b | PK₨14.0b | 12.5x | 21.1x | 1.1x |
| Tue, 20 Aug 2024 | PK₨259.1b | PK₨272.9b | PK₨9.7b | 16.1x | 26.8x | 0.9x |
| Thu, 18 Jul 2024 | PK₨273.0b | PK₨272.9b | PK₨9.7b | 14.2x | 28.2x | 1x |
| Sat, 15 Jun 2024 | PK₨263.1b | PK₨272.9b | PK₨9.7b | 14.6x | 27.2x | 1x |
| Mon, 13 May 2024 | PK₨242.9b | PK₨263.5b | PK₨10.4b | 15.7x | 23.3x | 0.9x |
| Wed, 10 Apr 2024 | PK₨206.8b | PK₨256.1b | PK₨8.3b | 19.6x | 24.9x | 0.8x |
| Fri, 08 Mar 2024 | PK₨187.7b | PK₨251.0b | PK₨8.0b | 12.6x | 23.4x | 0.7x |
| Sun, 04 Feb 2024 | PK₨179.1b | PK₨248.2b | PK₨7.9b | 12.7x | 22.7x | 0.7x |
| Tue, 02 Jan 2024 | PK₨189.8b | PK₨248.2b | PK₨7.9b | 14.1x | 24.1x | 0.8x |
| Thu, 30 Nov 2023 | PK₨188.0b | PK₨245.1b | PK₨7.8b | 14.3x | 24.1x | 0.8x |
| Sat, 28 Oct 2023 | PK₨158.4b | PK₨237.4b | PK₨8.2b | 12.1x | 19.3x | 0.7x |
| Mon, 25 Sep 2023 | PK₨140.0b | PK₨234.0b | PK₨9.9b | 10.9x | 14.1x | 0.6x |
| Wed, 23 Aug 2023 | PK₨149.7b | PK₨230.3b | PK₨10.4b | 11.4x | 14.4x | 0.7x |
| Fri, 21 Jul 2023 | PK₨158.0b | PK₨230.3b | PK₨10.4b | 12.6x | 15.2x | 0.7x |
| Sun, 18 Jun 2023 | PK₨147.6b | PK₨230.3b | PK₨10.4b | 11.4x | 14.2x | 0.6x |
| Tue, 16 May 2023 | PK₨154.3b | PK₨218.4b | PK₨14.3b | 10.7x | 10.8x | 0.7x |
| Thu, 13 Apr 2023 | PK₨154.8b | PK₨217.1b | PK₨15.1b | 9.3x | 10.2x | 0.7x |
| Sat, 11 Mar 2023 | PK₨159.8b | PK₨214.7b | PK₨16.5b | 9.1x | 9.7x | 0.7x |
| Mon, 06 Feb 2023 | PK₨156.6b | PK₨211.8b | PK₨16.8b | 8.7x | 9.3x | 0.7x |
| Wed, 04 Jan 2023 | PK₨174.4b | PK₨211.8b | PK₨16.8b | 9.8x | 10.4x | 0.8x |
| Fri, 02 Dec 2022 | PK₨201.5b | PK₨210.0b | PK₨16.6b | 10.9x | 12.1x | 1x |
| Sun, 30 Oct 2022 | PK₨209.0b | PK₨204.3b | PK₨18.9b | 11x | 11.1x | 1x |
| Tue, 27 Sep 2022 | PK₨213.9b | PK₨200.0b | PK₨20.2b | 10.6x | 10.6x | 1.1x |
| Thu, 25 Aug 2022 | PK₨232.7b | PK₨189.9b | PK₨23.3b | 9.9x | 10x | 1.2x |
| Sat, 23 Jul 2022 | PK₨227.7b | PK₨188.5b | PK₨23.1b | 9.8x | 9.8x | 1.2x |
Price to Earnings Ratio
9.8x
Current Industry PE
- Investors are relatively neutral on the Pakistani Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 18.2x.
- The 3-year average PS ratio of 1.0x is lower than the industry's current PS ratio of 1.8x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 7.3% per year over the last three years.
- Revenues for these companies have grown 18% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Pakistani Healthcare sector?
| PK Market | 0.95% | |
| Healthcare | -2.09% | |
| Healthcare Services | -1.51% | |
| Pharma | -1.85% | |
| Life Sciences | -8.12% | |
Industry PE
- Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 54.3x.
- It looks like they are confident that earnings will grow faster in the future than they have historically.
- Investors are most pessimistic about the Pharma industry, which is trading close to its 3-year average of 19.1x.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 35% over the next 5 years.
- However this is lower than its past earnings growth rate of 53% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 35% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| HINOON Highnoon Laboratories | PK₨1.08k | 5.5% +PK₨2.9b | 51.6% | PE16.1x | |
| AGP AGP | PK₨199.63 | 0.6% +PK₨308.0m | 96.7% | PE17.9x | |
| ABOT Abbott Laboratories (Pakistan) | PK₨1.09k | 0.1% +PK₨128.2m | 36.5% | PE20x | |
| FEROZ Ferozsons Laboratories | PK₨390.07 | 0.5% +PK₨89.1m | 53.1% | PE22.5x | |
| IBLHL IBL HealthCare | PK₨64.19 | 1.2% +PK₨66.8m | 101.8% | PS1.5x |